These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38175863)

  • 1. Lipid shape and packing are key for optimal design of pH-sensitive mRNA lipid nanoparticles.
    Tesei G; Hsiao YW; Dabkowska A; Grönberg G; Yanez Arteta M; Ulkoski D; Bray DJ; Trulsson M; Ulander J; Lund M; Lindfors L
    Proc Natl Acad Sci U S A; 2024 Jan; 121(2):e2311700120. PubMed ID: 38175863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DOPC
    Ermilova I; Swenson J
    Phys Chem Chem Phys; 2020 Dec; 22(48):28256-28268. PubMed ID: 33295352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function.
    Philipp J; Dabkowska A; Reiser A; Frank K; Krzysztoń R; Brummer C; Nickel B; Blanchet CE; Sudarsan A; Ibrahim M; Johansson S; Skantze P; Skantze U; Östman S; Johansson M; Henderson N; Elvevold K; Smedsrød B; Schwierz N; Lindfors L; Rädler JO
    Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2310491120. PubMed ID: 38055742
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Algarni A; Pilkington EH; Suys EJA; Al-Wassiti H; Pouton CW; Truong NP
    Biomater Sci; 2022 May; 10(11):2940-2952. PubMed ID: 35475455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modular Design of Biodegradable Ionizable Lipids for Improved mRNA Delivery and Precise Cancer Metastasis Delineation In Vivo.
    Chen Z; Tian Y; Yang J; Wu F; Liu S; Cao W; Xu W; Hu T; Siegwart DJ; Xiong H
    J Am Chem Soc; 2023 Nov; 145(44):24302-24314. PubMed ID: 37853662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coarse-Grained Simulation of mRNA-Loaded Lipid Nanoparticle Self-Assembly.
    Grzetic DJ; Hamilton NB; Shelley JC
    Mol Pharm; 2024 Sep; 21(9):4747-4753. PubMed ID: 39145436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo.
    Biscans A; Ly S; McHugh N; Cooper DA; Khvorova A
    J Control Release; 2022 Sep; 349():831-843. PubMed ID: 35917865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.
    Misra B; Hughes KA; Pentz WH; Samart P; Geldenhuys WJ; Bobbala S
    Nanoscale; 2024 Apr; 16(14):6939-6948. PubMed ID: 38511623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the interactions between RNA and titrateable lipid layers: implications for RNA delivery with lipid nanoparticles.
    Gilbert J; Ermilova I; Fornasier M; Skoda M; Fragneto G; Swenson J; Nylander T
    Nanoscale; 2024 Jan; 16(2):777-794. PubMed ID: 38088740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function.
    Ramezanpour M; Schmidt ML; Bodnariuc I; Kulkarni JA; Leung SSW; Cullis PR; Thewalt JL; Tieleman DP
    Nanoscale; 2019 Aug; 11(30):14141-14146. PubMed ID: 31334542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
    Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
    Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy.
    Escalona-Rayo O; Zeng Y; Knol RA; Kock TJF; Aschmann D; Slütter B; Kros A
    Biomed Pharmacother; 2023 Sep; 165():115065. PubMed ID: 37406506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction Kinetics of Individual mRNA-Containing Lipid Nanoparticles with an Endosomal Membrane Mimic: Dependence on pH, Protein Corona Formation, and Lipoprotein Depletion.
    Aliakbarinodehi N; Gallud A; Mapar M; Wesén E; Heydari S; Jing Y; Emilsson G; Liu K; Sabirsh A; Zhdanov VP; Lindfors L; Esbjörner EK; Höök F
    ACS Nano; 2022 Dec; 16(12):20163-20173. PubMed ID: 36511601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-Dependent Phase Behavior and Stability of Cationic Lipid-mRNA Nanoparticles.
    Larson NR; Hu G; Wei Y; Tuesca AD; Forrest ML; Middaugh CR
    J Pharm Sci; 2022 Mar; 111(3):690-698. PubMed ID: 34774918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine Applications.
    Lam K; Leung A; Martin A; Wood M; Schreiner P; Palmer L; Daly O; Zhao W; McClintock K; Heyes J
    Adv Mater; 2023 Apr; 35(15):e2209624. PubMed ID: 36680477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.
    Park S; Choi YK; Kim S; Lee J; Im W
    J Chem Inf Model; 2021 Oct; 61(10):5192-5202. PubMed ID: 34546048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acidic pH-induced changes in lipid nanoparticle membrane packing.
    Koitabashi K; Nagumo H; Nakao M; Machida T; Yoshida K; Sakai-Kato K
    Biochim Biophys Acta Biomembr; 2021 Aug; 1863(8):183627. PubMed ID: 33901441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Payload distribution and capacity of mRNA lipid nanoparticles.
    Li S; Hu Y; Li A; Lin J; Hsieh K; Schneiderman Z; Zhang P; Zhu Y; Qiu C; Kokkoli E; Wang TH; Mao HQ
    Nat Commun; 2022 Sep; 13(1):5561. PubMed ID: 36151112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles.
    Sato Y; Okabe N; Note Y; Hashiba K; Maeki M; Tokeshi M; Harashima H
    Acta Biomater; 2020 Jan; 102():341-350. PubMed ID: 31733331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
    Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H
    J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.